Novel trifluoromethylquinoline derivatives as potent tubulin polymerization inhibitors with antitumor activity

Meng Mao(Guiyang Medical University), Xueling Meng(Guiyang Medical University), Xiaoping Zeng(Fujian Medical University), Xiangkai Kong(Guiyang Medical University), Ping Yi(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases), Heng Luo(Guiyang Medical University), Kun Liu(Southern University of Science and Technology), Bixue Xu(Guiyang Medical University), Jia Yu(Beth Israel Deaconess Medical Center), Guangcan Xu(Guiyang Medical University), Gang Yu(Shandong Normal University), Liangliang Hu(Guiyang Medical University), Sha Cheng(Central South University)
Bioorganic & Medicinal Chemistry
November 3, 2025
10.1016/j.bmc.2025.118472
Cited by 1

Related Papers

Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms
|Gut|2020|1.4k
A Lancet Commission on 70 years of women's reproductive, maternal, newborn, child, and adolescent health in China
|The Lancet|2021|579
Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19)
|Clinical Infectious Diseases|2020|556
Burosumab Therapy in Children with X-Linked Hypophosphatemia
|New England Journal of Medicine|2018|479
Prevalence of Autism Spectrum Disorder in China: A Nationwide Multi-center Population-based Study Among Children Aged 6 to 12 Years
|Neuroscience Bulletin|2020|468